These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30316562)

  • 1. Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy," international society for cellular therapies, montreal, canada, may 2, 2018.
    Piuzzi NS; Dominici M; Long M; Pascual-Garrido C; Rodeo S; Huard J; Guicheux J; McFarland R; Goodrich LR; Maddens S; Robey PG; Bauer TW; Barrett J; Barry F; Karli D; Chu CR; Weiss DJ; Martin I; Jorgensen C; Muschler GF
    Cytotherapy; 2018 Nov; 20(11):1381-1400. PubMed ID: 30316562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the ISCT scientific signature series symposium, "Advances in cell and gene therapies for lung diseases and critical illnesses": International Society for Cell & Gene Therapy, Burlington VT, US, July 16, 2021.
    Ting AE; Baker EK; Champagne J; Desai TJ; Dos Santos CC; Heijink IH; Itescu S; Le Blanc K; Matthay MA; McAuley DF; McIntyre L; Mei SHJ; Parekkadan B; Rocco PRM; Sheridan J; Thébaud B; Weiss DJ
    Cytotherapy; 2022 Aug; 24(8):774-788. PubMed ID: 35613962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.
    Prządka P; Buczak K; Frejlich E; Gąsior L; Suliga K; Kiełbowicz Z
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
    Ciccocioppo R; Dos Santos CC; Baumgart DC; Cangemi GC; Cardinale V; Ciacci C; De Coppi P; Haldar D; Klersy C; Nostro MC; Ott M; Piemonti L; Tomei AA; Uygun B; Vetrano S; Orlando G
    Cytotherapy; 2018 Mar; 20(3):461-476. PubMed ID: 29398624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Cell Therapy Survival and Anabolism in Harsh Musculoskeletal Disease Environments.
    Farhang N; Silverman L; Bowles RD
    Tissue Eng Part B Rev; 2020 Aug; 26(4):348-366. PubMed ID: 32070243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell therapy in orthopaedics: where are we in 2019?
    Rodeo SA
    Bone Joint J; 2019 Apr; 101-B(4):361-364. PubMed ID: 30929493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?
    Mocchi M; Dotti S; Bue MD; Villa R; Bari E; Perteghella S; Torre ML; Grolli S
    Cells; 2020 Jun; 9(6):. PubMed ID: 32545382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADSC-Based Cell Therapies for Musculoskeletal Disorders: A Review of Recent Clinical Trials.
    Lee S; Chae DS; Song BW; Lim S; Kim SW; Kim IK; Hwang KC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current 'state of play' of regenerative medicine in horses: what the horse can tell the human.
    Smith RK; Garvican ER; Fortier LA
    Regen Med; 2014; 9(5):673-85. PubMed ID: 25372081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell, tissue and gene products with marketing authorization in 2018 worldwide.
    Cuende N; Rasko JEJ; Koh MBC; Dominici M; Ikonomou L
    Cytotherapy; 2018 Nov; 20(11):1401-1413. PubMed ID: 30366616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee.
    Nolta JA; Galipeau J; Phinney DG
    Cytotherapy; 2020 Mar; 22(3):123-126. PubMed ID: 32067856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A changing time: the International Society for Cellular Therapy embraces its industry members.
    Deans R; Gunter KC; Allsopp T; Bonyhadi M; Burger SR; Carpenter M; Clark T; Cox CS; Driscoll D; Field E; Huss R; Lardenoije R; Lodie TA; Mason C; Neubiser R; Rasko JE; Rowley J; Maziarz RT
    Cytotherapy; 2010 Nov; 12(7):853-6. PubMed ID: 20942603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.
    Dominici M; Nichols K; Srivastava A; Weiss DJ; Eldridge P; Cuende N; Deans RJ; Rasko JE; Levine AD; Turner L; Griffin DL; O'Donnell L; Forte M; Mason C; Wagena E; Janssen W; Nordon R; Wall D; Ho HN; Ruiz MA; Wilton S; Horwitz EM; Gunter KC;
    Cytotherapy; 2015 Dec; 17(12):1663-6. PubMed ID: 26589750
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular therapy injections in today's orthopedic market: A social media analysis.
    Ramkumar PN; Navarro SM; Haeberle HS; Chughtai M; Demetriades C; Piuzzi NS; Mont MA; Bauer TW; Muschler GF
    Cytotherapy; 2017 Dec; 19(12):1392-1399. PubMed ID: 28916228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular regenerative therapy for acquired noncongenital musculoskeletal disorders.
    Niesler CU; Van de Vyver M; Myburgh KH
    S Afr Med J; 2019 Sep; 109(8b):58-63. PubMed ID: 31662151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule based musculoskeletal regenerative engineering.
    Lo KW; Jiang T; Gagnon KA; Nelson C; Laurencin CT
    Trends Biotechnol; 2014 Feb; 32(2):74-81. PubMed ID: 24405851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Expert Consensus on a Cell Therapy Communication Tool: DOSES.
    Murray IR; Chahla J; Safran MR; Krych AJ; Saris DBF; Caplan AI; LaPrade RF;
    J Bone Joint Surg Am; 2019 May; 101(10):904-911. PubMed ID: 31094982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP).
    Manchikanti L; Centeno CJ; Atluri S; Albers SL; Shapiro S; Malanga GA; Abd-Elsayed A; Jerome M; Hirsch JA; Kaye AD; Aydin SM; Beall D; Buford D; Borg-Stein J; Buenaventura RM; Cabaret JA; Calodney AK; Candido KD; Cartier C; Latchaw R; Diwan S; Dodson E; Fausel Z; Fredericson M; Gharibo CG; Gupta M; Kaye AM; Knezevic NN; Kosanovic R; Lucas M; Manchikanti MV; Mason RA; Mautner K; Murala S; Navani A; Pampati V; Pastoriza S; Pasupuleti R; Philip C; Sanapati MR; Sand T; Shah RV; Soin A; Stemper I; Wargo BW; Hernigou P
    Pain Physician; 2020 Mar; 23(2):E85-E131. PubMed ID: 32214287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man.
    de Bakker E; Van Ryssen B; De Schauwer C; Meyer E
    Vet Q; 2013 Dec; 33(4):225-33. PubMed ID: 24404887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.